Top Stories

Porinju Veliyath buys small-cap stocks below ₹100 in Q3

 



• Porinju Veliyath's name appears in the shareholding pattern of this small-cap stock

Porinju Veliyath Portfolio: The 'Jar of Small-Cap Stocks' has added Max India share to his portfolio during the October to December 2022 quarter. According to the latest shareholding pattern of Max India for the quarter ended December 2022, Porinju Veliyath's name has figured in the list of individual shareholders of the company. The company's shareholding data shows that Porinju Veliyath holds 1.05 per cent stake in the company.

Max India

+ Add to Watchlist

99.650.85 (0.86%)

Updated - January 13, 2023

100.90

high day

98.95

day less

116.00

Vol (BSE)


Porinju Veliyath's shareholding in Max India

As per the shareholding pattern of Max India for the December 2022 quarter, Porinju Veliyath holds 4.50 lakh shares, which is 1.05 per cent of the company's total paid-up capital. However, Porinju Veliyath's name did not figure in the list of individual shareholders of the company for the July to September 2022 quarter. This means that Market Magnates bought fresh stake in the company during the October to December 2022 quarter.

Click here to read the latest news of the stock market

However, it would be difficult to establish whether all these shares were bought by Porinju Veliyath during the recently ended October to December 2022 quarter or he held some stake in the company and added some more during the recently ended quarter of the current financial year. were. As per the shareholding pattern rule, a listed company is bound to share the names of all individual shareholders who hold 1 per cent or more stake in the company.

max india share price history

Max India shares are one of the small-cap stocks listed on Dalal Street. Max India share price ended at ₹98.90 in Thursday's session on NSE. This small-cap stock is in an uptrend since last few months. In the last one month, the Porinju Veliyath-owned stock has gained up to 6 per cent, while in the last six months, this small-cap scrip has gained over 30 per cent.

No comments: